Goldman Sachs’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.2M | Buy |
|
|||||
|
2025
Q1 | $13.7M | Buy |
|
|||||
|
2024
Q4 | $24.4M | Buy |
|
|||||
|
2024
Q3 | $26.3M | Buy |
|
|||||
|
2024
Q2 | $7.72M | Buy |
|
|||||
|
2024
Q1 | $4.21M | Sell |
|
|||||
|
2023
Q4 | $6.68M | Buy |
|
|||||
|
2023
Q3 | $1.68M | Sell |
|
|||||
|
2023
Q2 | $2.06M | Sell |
|
|||||
|
2023
Q1 | $5.95M | Sell |
|
|||||
|
2022
Q4 | $15.4M | Buy |
|
|||||
|
2022
Q3 | $13.9M | Sell |
|
|||||
|
2022
Q2 | $37.1M | Sell |
|
|||||
|
2022
Q1 | $92.5M | Sell |
|
|||||
|
2021
Q4 | $140M | Sell |
|
|||||
|
2021
Q3 | $117M | Buy |
|
|||||
|
2021
Q2 | $59.9M | Buy |
|
|||||
|
2021
Q1 | $47.3M | Sell |
|
|||||
|
2020
Q4 | $58.2M | Sell |
|
|||||
|
2020
Q3 | $69.8M | Sell |
|
|||||
|
2020
Q2 | $69.5M | Buy |
|
|||||
|
2020
Q1 | $32.3M | Sell |
|
|||||
|
2019
Q4 | $44.7M | Buy |
|
|||||
|
2019
Q3 | $36.3M | Buy |
|
|||||
|
2019
Q2 | $37M | Sell |
|
|||||
|
2019
Q1 | $37M | Buy |
|
|||||
|
2018
Q4 | $19.6M | Sell |
|
|||||
|
2018
Q3 | $34.1M | Buy |
|
|||||
|
2018
Q2 | $244K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $79K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $69K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $73K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $315K | Sell |
|
|||||
|
2015
Q2 | $480K | Buy |
|
|||||
|
2015
Q1 | $327K | Sell |
|
|||||
|
2014
Q4 | $1.31M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $8.06M | Buy |
|